Bluesky Facebook Reddit Email

Waiting Can Kill:

Researchers recommend strategies to manage queues and waiting lines, including paying bills by mail and avoiding in-person registration. Dr. Richard C. Larson suggests that fair standing queues, such as merging traffic, can help reduce frustration with waiting.

Humor Is Serious Business For Cincinnati Marketing Researchers

Cincinnati marketing researchers have created a comprehensive test to measure an individual's need for levity, exploring the link between humor, whimsy, and human behavior. The study found that people tend to score high on external-humor, with men perceiving themselves as jokesters more often than women.

Apple iPad Pro 11-inch (M4)

Apple iPad Pro 11-inch (M4) runs demanding GIS, imaging, and annotation workflows on the go for surveys, briefings, and lab notebooks.

Hopkins Bayview Researcher Chips Away At Olestra Controversy

A Johns Hopkins Bayview researcher's double-blind study found that potato chips made with olestra don't cause more digestive problems than regular-fat chips. The study of over 1,100 participants suggests that digestive symptoms are common in the general population and that fat substitutes may be a valuable tool for weight management.

Science Magazine And Amersham Pharmacia Biotech Honor Young Biologists

The winners, Christine Jacobs, James E. Brownell, Georg Halder, and Mitsuharu Hattori, have made groundbreaking discoveries in bacterial resistance, genetic function regulation, eye development, and brain development research. They will receive $5,000 each plus a grand prize of $20,000.

ZBLAN Research Takes Step Forward

Researchers have made significant breakthroughs with ZBLAN material, a potential game-changer for optical fiber communications. Made in space, ZBLAN exhibits properties that far exceed current state-of-the-art materials, offering vast potential for applications in fields like medical surgery and temperature monitoring.

Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

Copolymer1 Gets FDA Approval

Copolymer-1 has been approved by the FDA for treatment of relapsing-remitting multiple sclerosis, demonstrating its ability to reduce attack frequency and minimize negative side effects. The drug works by blocking the immune system's attack on myelin coatings and triggering immune suppressor cells.